Denosumab: a new option in the treatment of bone metastases from urological cancers

Overview of attention for article published in OncoTargets and therapy, September 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Nanoparticles for drug delivery to treat bone disease

Grant US-11013817-B2

United States of America

NANOPARTICLES FOR DRUG DELIVERY TO TREAT BONE DISEASE

Application WO-2017177134-A1

World Intellectual Property Organisation (WIPO)

RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE

Application WO-2016075221-A1

World Intellectual Property Organisation (WIPO)